Young Joseph R's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed May 17, 2024
- Accession no.
- 0001415889-24-013504
- Filed
- May 17, 2024
- Trade date
- May 15-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.30M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young Joseph RCIK 0001861684 | Officer (SVP, FINANCE, CHIEF ACCT OFFCR) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Class A Common Stock | MOption exerciseAcquired | +8,221 | $3.94 | +$32,390.74 | 61,392 | Direct | |
| May 15, 2024 | Class A Common Stock | SSaleDisposed | −8,221 | $42.17 | −$346,679.57 | 53,171 | Direct | |
| May 15, 2024 | Class A Common Stock | SSaleDisposed | −1,965 | $42.68 | −$83,866.2 | 51,206 | Direct | |
| May 16, 2024 | Class A Common Stock | MOption exerciseAcquired | +18,151 | $7.87 | +$142,848.37 | 69,357 | Direct | |
| May 16, 2024 | Class A Common Stock | SSaleDisposed | −18,151 | $42.22 | −$766,335.22 | 51,206 | Direct | |
| May 16, 2024 | Class A Common Stock | MOption exerciseAcquired | +2,500 | $7.87 | +$19,675 | 53,706 | Direct | |
| May 16, 2024 | Class A Common Stock | SSaleDisposed | −2,500 | $43.03 | −$107,575 | 51,206 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Class A Common Stock | MOption exerciseDisposed | −8,221 | $0.00 | $0 | 58,589 | Direct | |
| May 16, 2024 | Class A Common Stock | MOption exerciseDisposed | −20,651 | $0.00 | $0 | 69,349 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.